Next Article in Journal
Secretomics to Discover Regulators in Diseases
Next Article in Special Issue
Topographical Visualization of the Reciprocal Projection between the Medial Septum and the Hippocampus in the 5XFAD Mouse Model of Alzheimer’s Disease
Previous Article in Journal
Vanin 1: Its Physiological Function and Role in Diseases
Previous Article in Special Issue
Preventive Effects of Tryptophan–Methionine Dipeptide on Neural Inflammation and Alzheimer’s Pathology

Ketogenic Diet in Alzheimer’s Disease

Department of Pathophysiology, Medical University of Lublin, 20-090 Lublin, Poland
Department of Dermatology, Venereology and Pediatric Dermatology, Laboratory for Immunology of Skin Diseases, Medical University of Lublin, 20-080 Lublin, Poland
Laboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Centre, Polish Academy of Sciences, 02-106 Warsaw, Poland
First Department of Neurology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(16), 3892;
Received: 21 July 2019 / Revised: 5 August 2019 / Accepted: 7 August 2019 / Published: 9 August 2019
At present, the prevalence of Alzheimer’s disease, a devastating neurodegenerative disorder, is increasing. Although the mechanism of the underlying pathology is not fully uncovered, in the last years, there has been significant progress in its understanding. This includes: Progressive deposition of amyloid β-peptides in amyloid plaques and hyperphosphorylated tau protein in intracellular as neurofibrillary tangles; neuronal loss; and impaired glucose metabolism. Due to a lack of effective prevention and treatment strategy, emerging evidence suggests that dietary and metabolic interventions could potentially target these issues. The ketogenic diet is a very high-fat, low-carbohydrate diet, which has a fasting-like effect bringing the body into a state of ketosis. The presence of ketone bodies has a neuroprotective impact on aging brain cells. Moreover, their production may enhance mitochondrial function, reduce the expression of inflammatory and apoptotic mediators. Thus, it has gained interest as a potential therapy for neurodegenerative disorders like Alzheimer’s disease. This review aims to examine the role of the ketogenic diet in Alzheimer’s disease progression and to outline specific aspects of the nutritional profile providing a rationale for the implementation of dietary interventions as a therapeutic strategy for Alzheimer’s disease. View Full-Text
Keywords: Alzheimer’s disease; ketogenic diet; amyloid; tau protein; neuroinflammation; dementia; ketone bodies therapy Alzheimer’s disease; ketogenic diet; amyloid; tau protein; neuroinflammation; dementia; ketone bodies therapy
Show Figures

Figure 1

MDPI and ACS Style

Rusek, M.; Pluta, R.; Ułamek-Kozioł, M.; Czuczwar, S.J. Ketogenic Diet in Alzheimer’s Disease. Int. J. Mol. Sci. 2019, 20, 3892.

AMA Style

Rusek M, Pluta R, Ułamek-Kozioł M, Czuczwar SJ. Ketogenic Diet in Alzheimer’s Disease. International Journal of Molecular Sciences. 2019; 20(16):3892.

Chicago/Turabian Style

Rusek, Marta, Ryszard Pluta, Marzena Ułamek-Kozioł, and Stanisław J. Czuczwar. 2019. "Ketogenic Diet in Alzheimer’s Disease" International Journal of Molecular Sciences 20, no. 16: 3892.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop